Novamind reports revenues of CAD$1.86 million for Q1 fiscal 2022, a 113% year-over-year increase. The company has total working capital of CAD$6.8 million

Red Light Holland reports its results for Q2 fiscal 2021. – Quarterly revenues up to CAD$485,738 – A 64% increase in gross profit
– 56% increase in the number of retail outlets selling TRIP products

A Florida lawmaker introduced a bill last week to decriminalize all currently illicit drugs, provide avenues for relief for those with existing drug-related convictions and promote harm reduction services.

Cybin seeks FDA approval for a new Phase 2 clinical trial aimed at treating “distress” among frontline healthcare practitioners.

UK-based Albert Labs receives conditional approval from the Canadian Securities Exchange (CSE) to commence trading under the symbol “ABRT”. Trading expected to commence in early 2022.